Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway have?
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway has 51 citations in the OpenAlex counts ScholarIQ stores.
When was Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway published?
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway has 2020 year in the ScholarIQ index.
What is the open-access status of Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway?
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway has green oa status in the ScholarIQ index.
What is the DOI of Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway?
The DOI for Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway is on the source record.
What is the PMID of Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway?
The PMID for Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway is on the source record.
What is the OpenAlex record for Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway?
The OpenAlex for Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway is on the source record.